September 2024 ZOHU Call/Webinar

What to know

A video recording of this webinar is posted below. Visit CDC TRAIN to get free continuing education (CE) for this webinar.

1 hour

Sep 4, 2024

Webinar details

Presentation topics

  • Rocky Mountain Spotted Fever: A Disease of Binational Concern
  • Building Momentum for Public Health Impact: The National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People
  • Lymphocytic Choriomeningitis Virus

Zoonoses and One Health Updates (ZOHU) Newsletter‎‎‎

Subscribe to the newsletter to receive monthly ZOHU news and updates.

Watch the webinar

Featuring

Ann Carpenter, DVM, MPH, DACVPM | Presenter
Veterinary Medical Officer
Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention
Maureen Brophy, PhD, MPH | Presenter
Epidemiologist
Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention
Susanna Visser, DrPH, MS | Presenter
Deputy Director for Policy and Extramural Program
Centers for Disease Control and Prevention
Kami Smith, MD, MPH | Presenter
Epidemic Intelligence Service Officer
Viral Special Pathogens Branch, Centers for Disease Control and Prevention

Continuing Education (CE)

Visit CDC Train to receive continuing education (CE).

Webcast (Live)

  • Course Name: WC4565(SC)-090424
  • Registration Code: ZOHUwebcast
  • Start Date: September 4, 2024
  • End Date: October 7, 2024

Web-on-Demand (Recording)

  • Course Name: WD4565(SC)-090424
  • Start Date: October 8, 2024
  • End Date: October 8, 2026

Series objectives

1. Identify an implication for human, animal, and environmental health.

2. Identify a One Health approach strategy for prevention of public health threats.

3. Identify a One Health approach strategy for detection of public health threats.

4. Identify a One Health approach strategy for responding to public health threats.

5. List two ways to improve collaborative practice across the public healthcare team.

Disclosures

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial or in-kind support for this activity.

Resources